Latka logo
Abcuro logo

Abcurorevenue

Newton, MassachusettsFounded 2015CEO Alex Martin

Abcuro is a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of immune responses.

abcuro.comLinkedInUpdated Sep 10, 2026
Annual revenue
$10.2M
Sep 2025EST
Employees
55
Sep 2025

Abcuro revenue

Abcuro has not published its revenue. Growjo puts it at about $10.2M a year (September 2025).

$0
$5M
$10M
$0
–
$10.2M
20152016–242025
ReportedEstimateFounded 2015 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$10.2MESTGrowjo estimate

Abcuro CEO & employees

Alex Martin is CEO of Abcuro. Abcuro has 55 employees (September 2025, LinkedIn).

0
20
40
55
2025
ReportedOne figure per year; a reported figure wins over an estimate

Abcuro FAQ

What is Abcuro's revenue?

Growjo estimates Abcuro's revenue at about $10.2M a year (September 2025). The company hasn't published its own figure.

How many employees does Abcuro have?

Abcuro has 55 employees as of September 2025, according to LinkedIn.

Who is the CEO of Abcuro?

Alex Martin is the CEO of Abcuro.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Abcuro? Join the podcast